There is hardly any way for CBD products to be absent in the list of trending products in the current markets. The hype they have been creating since launch is obvious. CBD is a young kid in the market with its legalization in 2018 by the Farm Bill that put hemp CBD in the list of agricultural products.
A great deal of clinical research happens prior to the release of a medicinal product into the market. After all, you can’t take chances with the health of the consumers. Things are quite the same with CBD too and a great deal of homework and clinical research was done before its launch.
A bit of research about clinical research
Research of chemical compounds begins in the labs in vitro before progressing to animal and human studies. Primarily, the biochemical mechanisms of the chemical compound have to be understood well before even thinking of trying it on living organisms.
CBD Clinical Trials for Various Medical Conditions
CBD clinical trials – Epilepsy
Several studies were conducted to determine the effectiveness of CBD in reducing seizure symptoms in epilepsy patients.
The first large scale study was conducted in 2015 with 214 patients suffering from Lennox-Gastaut syndrome, Dravet syndrome and several other pediatric epilepsies. The study found out that the treatment reduced the seizures in 36.5% of the patients.
2016 Israeli study
The study was conducted with 74 patients and they were given oil with 20:1 CBD to THC ratio. The study reported an 89% seizure frequency reduction, and also noted improvement in sleep, cognition and behavior.
CBD Clinical Trials – Schizophrenia and Psychosis
Defects in learning, memory, attention etc are the common signs of schizophrenia and this can have a negative impact on daily living. The anti-psychotic and anti –inflammatory properties of CBD make it a promising medication for schizophrenia.
CBD Clinical Trials – Addiction
Animal studies have suggested that cannabidiol can modulate various neuronal circuits involved in substance addiction. A study of 24 smokers who wished to quit the habit indicated the potential of CBD in treating substance addiction. The people were given inhalers with CBD content, and they reported significant reduction in their cravings for nicotine.
CBD is used more as a symptom-relieving medication and not as one that treats the disease itself. Before suggesting CBD as a cure for diseases of varying nature, a decent number of research and clinical studies have to confirm the proposed benefits.